Covered with prior authorization — benefit depends on your employer
Does Cigna Cover Zepbound in 2026?
Yes — Cigna still covers Zepbound with prior authorization on plans that include weight-loss drug benefits. Zepbound sits on Cigna's national formularies (it's even listed as a preferred alternative for people coming off Saxenda), and the current policy grants an 8-month initial approval when you meet the BMI and lifestyle criteria below. The two things that actually stop people: an employer that never bought the weight-loss benefit, and — as of June 2026 — the uncomfortable headline that Cigna dropped GLP-1 coverage for its own employees.
We archived Cigna's three governing documents on July 22, 2026: the prior-authorization policy (cnf_684), the Zepbound quantity-limit policy (cnf_840), and the per-claim limit policy (cnf_894). Everything below quotes those documents. The whole picture in one table:
| Path | Who qualifies | Status |
|---|---|---|
| Plan with weight-loss benefit | Employer plans that include weight-loss drugs | Covered with PA: BMI ≥ 30 (or ≥ 27 + comorbidity) + 3-month lifestyle trial → 8-month approval |
| Sleep apnea pathway | Moderate-to-severe OSA (AHI ≥ 15) + BMI ≥ 30 | Covered with PA — 1-year approvals on its own criteria |
| Plan without the benefit | Employers that excluded weight-loss drugs (incl. Cigna's own employee plan since July 1, 2026) | Denied regardless of criteria; exception request or cash pay |
| Medicare GLP-1 Bridge | Part D enrollees meeting BMI criteria | $50/month copay through December 31, 2027 (KwikPen only) |
Does Cigna cover Zepbound for weight loss?
On plans with the benefit, yes. Cigna's policy cnf_684 (reviewed July 9, 2025, with revisions through April 2026) approves Zepbound for "Weight Loss in an Adult with Overweight or Obesity" for 8 months initially, when all of the following hold:
- You are 18 or older.
- You have "engaged in a trial of behavioral modification and dietary restriction for at least 3 months."
- Baseline BMI of 30 or higher — or 27 or higher with at least one weight-related comorbidity. Cigna's list is unusually generous: "hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, cardiovascular disease, knee osteoarthritis, asthma, chronic obstructive pulmonary disease, metabolic dysfunction-associated steatotic liver disease/non-alcoholic fatty liver disease, polycystic ovarian syndrome, or coronary artery disease."
- The medication is used "concomitantly with behavioral modification and a reduced-calorie diet."
Two details work in your favor. Cigna's lifestyle requirement is 3 months — half of Aetna's 6 — and it accepts a much longer comorbidity list for the 27–30 BMI band (knee osteoarthritis, asthma, PCOS, and fatty liver disease all count; most insurers stop at the classic three). And the baseline rule is switcher-friendly: BMI counts from "baseline prior to any glucagon-like peptide-1 (GLP-1) agonist," so weight you already lost on Wegovy or Saxenda doesn't disqualify you — bring the chart note showing your starting BMI.
Why Cigna dropped GLP-1s for its own employees
On June 2, 2026, Reuters reported that the Cigna Group Medical Plan — the plan covering Cigna's own roughly 67,700 employees — dropped Wegovy and Zepbound for weight loss effective July 1, 2026, with refills allowed through June 30. Diabetes coverage (Mounjaro, Ozempic) was untouched.
Here is what that news does and doesn't mean for you. It does not change client plans: the formularies and the cnf_684 criteria above still govern the employer plans Cigna administers, and our archived copy of Cigna's 2025 drug-list changes shows no Zepbound removal on any national formulary. What it does tell you is which direction the wind blows — when an insurer decides GLP-1 coverage is too expensive for its own workforce, employer clients hear about it, and benefit elections happen every fall. If your plan covers Zepbound today, the practical advice is: get your PA submitted and documented now, and read your open-enrollment materials closely this autumn. A formulary you qualify under this year can be a formulary your employer drops next year.
The quantity limits: 4 pens per 28 days, no overrides
Approval is not the only gate — two quantity policies sit behind it. cnf_840 caps Zepbound at "2 mL (4 pens or vials) per 28 days" at retail, or 12 per 84 days by home delivery, at every strength — and states flatly: "There are no overrides to the Per Days quantity limits outlined below." cnf_894 adds a claim-spacing rule: one GLP-1 fill per 21 days.
The practical consequence: a "monthly" fill on Cigna is a 28-day fill, and there is no early-refill exception to bank doses before travel or a coverage change. Plan refill timing accordingly — the 21-day spacing rule means the earliest you can fill is three weeks after the last claim.
Coverage for sleep apnea
Zepbound's second FDA indication gets its own section of cnf_684: "Obstructive Sleep Apnea, Moderate to Severe, in a Patient with Obesity" — approved for 1 year when you're 18 or older with a baseline BMI of 30 or higher and a sleep study showing an apnea-hypopnea index of 15 or more events per hour.
Note the asymmetries against the weight-loss pathway: OSA approvals run 1 year from the start (not 8 months), but renewal is stricter — continuation requires at least 10% weight loss from baseline plus stable OSA symptoms, versus 5% on the weight-loss pathway. If you qualify both ways, that difference is worth discussing with your prescriber before the first submission.
How to check your plan (including Open Access Plus)
Open Access Plus, LocalPlus, SureFit, HDHP — the network name on a Cigna card says nothing about drug coverage. What decides your case is which drug list your plan uses (Standard, Performance, Advantage, Legacy, or National Preferred) and whether your employer included weight-loss drug benefits at all. Three ways to get the answer, fastest first:
- Price the drug on myCigna. The "Price a Medication" tool on myCigna.com checks Zepbound against your actual plan and shows the PA flag and your tier cost — the same data the pharmacy sees.
- Call the member line (number on your card) and ask three questions in order: "Does my plan include weight-loss drug coverage? Is Zepbound on my drug list? What prior authorization criteria apply?" Write down the representative's name and reference number.
- Ask HR one question: "Did our plan include weight-loss drug coverage this year?" Self-funded employers own that decision — and after Cigna's own-employee news, it's a fair question to ask about next year too.
Renewal rules: how long approvals last
The initial weight-loss approval runs 8 months. After that, cnf_684's continuation section ("Patient is Currently Receiving Zepbound") grants 1-year renewals when you've "lost ≥ 5% of baseline body weight" — with baseline again measured before any GLP-1 therapy, so early progress counts permanently in your favor.
The renewal failure we see most in user reports isn't missing the 5% — tirzepatide's trial averages run far higher — it's the 5% not being documented anywhere the insurer accepts. Have your prescriber record weight at every visit from day one; a dated chart note beats a home-scale screenshot.
If you're denied
Read the denial letter for which case you're in — the fix depends on it.
- PA denial on a plan with the benefit: usually a missing piece — the 3-month lifestyle record, the baseline BMI note, or comorbidity documentation for the 27–30 band. Request the reason in writing, resubmit with the missing document, then use the internal appeal if needed. Past that, every state provides external review by an independent physician, and it overturns insurer denials often enough to be worth the paperwork.
- Benefit exclusion (your plan doesn't cover weight-loss drugs): appeals rarely overturn the exclusion itself. The moves that work: the sleep apnea pathway if the diagnosis fits, a formulary-exception request through your prescriber (strongest with documented failure on covered alternatives), or cash pay below.
Cigna's grievance timelines give internal appeals a decision window of 30 days for pre-service requests. If you're mid-therapy when a denial hits, ask your prescriber about an expedited review — a treatment interruption on a working dose is exactly the situation expedited reviews exist for.
Cost with and without coverage
What Cigna's answer means for your monthly out-of-pocket on Zepbound, as of July 2026, using prices we verify and date on our provider pages:
| Path | Your monthly cost | Notes |
|---|---|---|
| Covered with PA | Plan copay, commonly $25–$100+ by tier | 28-day fills; your Summary of Benefits lists the exact tier copay |
| Medicare GLP-1 Bridge | $50 flat | KwikPen only; runs outside Part D through a CMS processor |
| Cash pay, telehealth programs | ~$299–$449 + program fees | Advertised prices often exclude membership; verified fee breakdowns on our provider comparison |
| Cash pay, retail pharmacy list price | ~$1,000–$1,400 | The price nobody should pay — LillyDirect and telehealth routes undercut it |
If you land on cash pay — including Cigna employees who just lost the benefit — our provider matcher filters verified telehealth programs by budget, and the cost calculator adds the membership fees programs leave out of headlines.
FAQ
Does Cigna cover Zepbound for weight loss?
Yes, with prior authorization, on plans that include weight-loss drug benefits: baseline BMI ≥ 30 (or ≥ 27 with a comorbidity from Cigna's list), a 3-month lifestyle trial, and age 18+. Initial approval runs 8 months.
How long does a Cigna Zepbound approval last?
8 months initially, then 1-year renewals if you've lost at least 5% of your pre-GLP-1 baseline weight and continue lifestyle modification.
Did Cigna stop covering Zepbound?
No — client formularies still list it, and our archived copy of Cigna's 2025 drug-list changes shows no Zepbound removal. What happened in June 2026: Cigna dropped Wegovy and Zepbound for weight loss on its own employees' plan, effective July 1, 2026. Your employer's plan is unaffected unless your employer makes the same election.
Does Cigna cover Zepbound for sleep apnea?
Yes — cnf_684 approves it for 1 year with BMI ≥ 30 and a sleep study showing AHI ≥ 15. Renewals require 10% weight loss plus stable symptoms.
How many Zepbound pens does Cigna cover per month?
4 pens or vials per 28 days at retail (12 per 84 days by home delivery), with no overrides, and no more than one GLP-1 claim per 21 days.
Does Cigna Open Access Plus cover Zepbound?
Open Access Plus is a network type, not a drug list — coverage depends on which formulary your employer chose and whether it includes weight-loss benefits. Price the drug on myCigna for your plan's answer.
Sources and update history
Primary documents, archived in our research records on July 22, 2026: Cigna coverage policy cnf_684 (GLP-1 prior authorization; reviewed 07/09/2025, revisions through 04/15/2026); cnf_840 (Zepbound quantity limits; reviewed 10/30/2024, revisions through 07/16/2025); cnf_894 (per-claim limits); Cigna's 2025 prescription drug list changes (137-page PDF). Employee-plan news: Reuters, "Cigna drops coverage of GLP-1 obesity drugs for its own employees," June 2, 2026 (verified against syndicated wire copies). Policies change quarterly — verify against the linked documents and your plan papers.